Epidermolysis bullosa acquisita develops in dominant dystrophic epidermolysis bullosa
Epidermolysis bullosa acquisita develops in dominant dystrophic epidermolysis bullosa
复制标题
获得性大疱性表皮松解症发生于显性营养不良性大疱性表皮松解症
DOI:
10.1038/jid.2015.370
复制
发表时间:
2016
影响因子:
6.5
通讯作者:
Shimomura Y
中科院分区:
文献类型:
--
作者:
Hayashi R;Natsuga K;Watanabe M;Iwata H;Shinkuma S;Ito A;Masui Y;Ito M;Shimomura Y
Dystrophic epidermolysis bullosa (DEB) is a congenital inherited blistering disorder caused by mutations in COL7A1, the gene encoding collagen VII (COL7), which is a major structural component of anchoring fibrils of the hemidesmosome. COL7 protein comprises a central triple helical domain flanked by a 145 kDa noncollagenous amino-terminal domain (NC1) and a 30 kDa carboxylterminal domain (Burgeson, 1993). DEB shows either autosomal dominant (DDEB; OMIM# 131750) or recessive (RDEB; OMIM# 226600) inheritance (Fine et al., 2014). In contrast, epidermolysis bullosa acquista (EBA) is a chronic, autoimmune, subepidermal blistering skin disease with circulating IgG antibodies against COL7 (Kim and Kim, 2013). In skin of patients with EBA, linear deposition of IgG and C3 along the dermal-epidermal junction (DEJ) is evident with direct immunofluorescence; additionally, indirect immunofluorescence with patient sera shows linear deposition of IgG along the dermal side of the DEJ on 1 M NaCl split skin of normal control individuals. In most cases of EBA, epitopes of the auto-antibodies are within the NC1 domain of COL7 (Lapiere et al., 1993). Interestingly, anti-COL7 antibodies can be generated in patients with RDEB (Pendaries et al., 2010; Tampoia et al., 2013; Woodley et al., 2014), or DEB pruriginosa, which is an allelic disorder of DDEB (OMIM# 604129)(Jedlickova et al., 2012). Besides these findings, whether DEB and EBA can coexist in a single individual is largely unknown. Here, we describe a rare case of DDEB complicated by EBA. We have seen a three-generation Japanese family with DDEB at Niigata University Hospital (Figure 1 a). All three affected individuals in the family showed blister formations on their hands and feet during early childhood, whereas other skin areas and oral mucosa were unaffected. The skin symptoms improved with aging and resulted in scar formation and dystrophic nails (Figure 1 bed). After obtaining institutional approval of experiments and written informed consent from the patients, we performed direct sequencing analysis and identified a recurrent heterozygous missense mutation c. 7868G> A (p. Gly2623Asp) in the COL7A1 gene of all three affected individuals (Supplementary Materials and Methods online)(Figure 1 e). On the basis of previous reports of DDEB with the identical mutation (Varki et al., 2007) or other missense mutations at the amino acid position 2623 (Christiano et al., 1995; Sawamura et al., 2006; Varki et al., 2007), we expected a good prognosis for the affected individuals in this family. To our surprise, however, the eldest patient in the family (I-1; Figure 1 a) eventually showed bullae and subsequent scar formation all over her body, including oral mucosa at the age of 63 (Figure 1 feh). Skin biopsy from her left arm revealed subepidermal bulla formation with dense infiltration of lymphocytes, eosinophils, and neutrophils (Figure 1 i). Although circulating autoantibodies against the NC16a domain of 180 kDa bullous pemphigoid antigen were not evident in blood test, we postulated that she might suffer from an autoimmune blistering disease. To test this hypothesis, we conducted a series of analyses with samples of this patient’s skin and serum (Supplementary Materials and Methods). Direct immunofluorescence with skin sections from this patient revealed linear deposition of IgG and C3 at the DEJ (Figure 1 j; data not shown). In addition, indirect immunofluorescence with 1 M NaCl split normal human skin sections and the patient’s serum clearly demonstrated linear deposition of IgG at the dermal side of the DEJ (Figure 1 k), suggesting that the antigen recognized by the auto …